Video observed treatment for TB patients. Belarus experience.

A. Skrahina (Minsk, Belarus), H. Hurevich (Minsk, Belarus), E. Ilyasova (Minsk, Belarus), V. Akulov (Minsk, Belarus), D. Klimuk (Minsk, Belarus), V. Grankov (Minsk, Belarus), A. Skrahin (Minsk, Belarus), M. Dara (Copenhagen, Denmark)

Source: Virtual Congress 2020 – Multidrug-resistant tuberculosis
Session: Multidrug-resistant tuberculosis
Session type: E-poster session
Number: 1590
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Skrahina (Minsk, Belarus), H. Hurevich (Minsk, Belarus), E. Ilyasova (Minsk, Belarus), V. Akulov (Minsk, Belarus), D. Klimuk (Minsk, Belarus), V. Grankov (Minsk, Belarus), A. Skrahin (Minsk, Belarus), M. Dara (Copenhagen, Denmark). Video observed treatment for TB patients. Belarus experience.. 1590

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Video observed treatment for tuberculosis patients in Belarus.
Source: International Congress 2018 – Challenges in treating tuberculosis and nontuberculous mycobacteria
Year: 2018



Video observed treatment for tuberculosis patients in Belarus
Source: International Congress 2017 – MDRTB: detection and management
Year: 2017

Belarus experience in video observed treatment for tuberculosis patients
Source: International Congress 2019 – Tuberculosis: a public health approach
Year: 2019

The effectiveness of the treatment of patients with TB in the condition adapted DOTS-strategy in Ukraine
Source: Annual Congress 2008 - Outcomes of tuberculosis treatment
Year: 2008


Video-observed treatment for tuberculosis patients in Belarus: findings from the first programmatic experience
Source: Eur Respir J , 49 (3) 1602049; DOI: 10.1183/13993003.02049-2016
Year: 2017


DOT versus self administration in TB treatment in pilot area of sector 4, Bucharest- 3 years early re-treatment analysis
Source: Eur Respir J 2004; 24: Suppl. 48, 362s
Year: 2004

TB detection in children in Moscow (Russia) as in low TB incidence region
Source: International Congress 2018 – Groups who are susceptible to tuberculosis: children, pregnant women and elderly people
Year: 2018


Which patients are (not) able to adhere to tuberculosis treatment? A study in a rural area in the northwest part of Turkey
Source: Eur Respir J 2005; 26: Suppl. 49, 428s
Year: 2005

High completion rates with directly observed preventive treatment (DOPT) of latent tuberculosis infection (LTBI) in Ethiopian immigrants (EI) to Israel
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I
Year: 2012

Treatment outcomes of tuberculosis patients under directly observed therapy (DOT) for three years
Source: Eur Respir J 2004; 24: Suppl. 48, 653s
Year: 2004

On-going TB treatment category for TB cases in Iasi county (Romania)
Source: Annual Congress 2009 - Tuberculosis control
Year: 2009

Number of tuberculosis (TB) cases reported by primary care physicians (PCPs) in India: Results of a 1-day point prevalence study in 880 urban cities and towns in India
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013


Follow-up of TB cases failing or defaulting the first TB treatment, in Romania
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012


A comparison of on-site versus remote physician follow up of directly observed preventive treatment (DOPT) for latent tuberculosis infection (LTBI) on completion rates
Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology II
Year: 2012

Practicing empirical anti-tuberculosis treatment (ATT) in suspected spinal tuberculosis (STB): Follow up of 33 cases from Sri Lanka, a limited resource setting with an intermediate disease burden
Source: Annual Congress 2011 - Extrapulmonary tuberculosis and surgical interventions
Year: 2011


Untimely found TB cases and causes of death among patients infected with HIV/TB and with TB alone in the Leningrad region
Source: Annual Congress 2010 - Tuberculosis in special populations
Year: 2010

First line anti-tuberculous drug resistance prevalence and its pattern among HIV infected patients in the national referral TB center, Iran
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009

Multidrug-resistance tuberculosis and HIV-infected patients, the effectiveness of the treatment in Ukraine
Source: Annual Congress 2010 - Tuberculosis drug resistance
Year: 2010


Treatment outcomes and deaths among multidrug-resistant tuberculosis (MDR-TB) patients in Gomel region, Belarus – 2009-2010
Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights
Year: 2013


Frequency of drug resistance and treatment results with standard chemotherapeutical regimen in patients with newly detected tuberculosis on the data of district hospital, Kiev
Source: Eur Respir J 2002; 20: Suppl. 38, 548s
Year: 2002